SIREN : 832223788
BIOAGRUMES is a French company founded 8 years ago, specialized in the sector Autres cultures non permanentes. Based in TIERCE (49125), this company of category PME shows in 2024 a revenue of 931 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 930 912 € | 909 910 € | 785 933 € | 812 086 € | 852 073 € | 560 833 € |
| Net income | -6 043 € | 4 370 € | 23 228 € | 379 € | -391 € | -639 € |
| EBITDA | 33 535 € | 40 966 € | 40 684 € | -127 523 € | -302 057 € | -73 774 € |
| Net margin | -0.6% | 0.5% | 3.0% | 0.0% | -0.0% | -0.1% |
In 2024, BIOAGRUMES achieves revenue of 931 k€. Over the period 2019-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +10.7%. Vs 2023: +2%. After deducting consumption (357 k€), gross margin stands at 574 k€, i.e. a rate of 62%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 34 k€, representing 3.6% of revenue. The operating margin remains fragile, requiring cost vigilance. Net income is negative at -6 k€ (-0.6% of revenue), which will impact equity.
930 912 €
574 009 €
33 535 €
10 449 €
-6 043 €
3.6%
The debt ratio (= Financial debt / Equity x 100) stands at 1241%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 3%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 21.9 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 1.4% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
1241.426%
2.859%
1.385%
21.883
28.3%
In 2024, the debt ratio of BIOAGRUMES (1241.43) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
In 2024, the financial autonomy of BIOAGRUMES (2.9%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
In 2024, the repayment capacity of BIOAGRUMES (21.88) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 116.08. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 65.4x. Operating income very largely covers interest expenses: high safety margin.
116.077
65.424
In 2024, the liquidity ratio of BIOAGRUMES (116.08) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2024, the interest coverage of BIOAGRUMES (65.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 95 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 140 days. Excellent situation: suppliers finance 45 days of the operating cycle (retail model). Inventory turnover is 93 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 120 days of revenue, i.e. 310 k€ to permanently finance. Notable WCR improvement over the period (-59%), freeing up cash.
309 929 €
95 j
140 j
93 j
120 j
Based on 138 transactions of similar company sales (all years), the value of BIOAGRUMES is estimated at 214 704 € (range 72 779€ - 347 403€). With an EBITDA of 33 535€, the sector multiple of 3.3x is applied. The price/revenue ratio is 0.41x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 138 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOAGRUMES with other companies in the same sector:
Voir toutes les statistiques du secteur Autres cultures non permanentes
The revenue of BIOAGRUMES in 2024 is 931 k€.
BIOAGRUMES recorded a net loss in 2024.
The headquarters of BIOAGRUMES is located in TIERCE (49125), in the department Maine-et-Loire.
The tax return of BIOAGRUMES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOAGRUMES operates in the sector Autres cultures non permanentes (NAF code 01.19Z). See the 'Sector positioning' section above to compare the company with its competitors.